medRxiv preprint doi: https://doi.org/10.1101/2020.07.28.20163329; this version posted July 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . 1 Identifying robust biomarkers of infection 2 through an omics-based meta-analysis 3 4 Ashleigh C Myall1,2, Simon Perkins1, David Rushton4, Jonathan David5, Phillippa Spencer6, 5 Andrew R Jones1,&, & Philipp Antczak1,3,&* 6 1Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, 7 United Kingdom 8 2Department of Mathematics, Imperial College London, London, United Kingdom 9 3Center for Molecular Medicine, University of Cologne, Cologne, Germany 10 4Defence and Security Analysis Division, Defence Science and Technology laboratory 11 (DSTL), Porton Down Salisbury, United Kingdom 12 5Chemical, Biological and Radiological Division, Defence Science and Technology 13 laboratory (DSTL), Porton Down Salisbury, United Kingdom 14 6Cyber and Information Systems Division, Defence Science and Technology laboratory 15 (DSTL), Porton Down, Salisbury, United Kingdom 16 17 *Corresponding author 18 E-mail:
[email protected] (PA) 19 &Joint Senior Authors 1 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.07.28.20163329; this version posted July 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.